These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30191760)

  • 1. A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.
    Shi L; Rocha M; Leak RK; Zhao J; Bhatia TN; Mu H; Wei Z; Yu F; Weiner SL; Ma F; Jovin TG; Chen J
    J Cereb Blood Flow Metab; 2018 Dec; 38(12):2073-2091. PubMed ID: 30191760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of neuroprotection in stroke.
    Chamorro Á; Lo EH; Renú A; van Leyen K; Lyden PD
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):129-135. PubMed ID: 33148815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system.
    Altenbernd J; Kuhnt O; Hennigs S; Hilker R; Loehr C
    J Neurointerv Surg; 2018 May; 10(5):434-439. PubMed ID: 28821628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies.
    Molina CA; Saver JL
    Stroke; 2005 Oct; 36(10):2311-20. PubMed ID: 16179577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refocusing Neuroprotection in Cerebral Reperfusion Era: New Challenges and Strategies.
    Xiong XY; Liu L; Yang QW
    Front Neurol; 2018; 9():249. PubMed ID: 29740385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to neuroprotective drug development.
    Fisher M
    Stroke; 2011 Jan; 42(1 Suppl):S24-7. PubMed ID: 21164111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis.
    Leng X; Fang H; Leung TW; Mao C; Xu Y; Miao Z; Liu L; Wong KS; Liebeskind DS
    Cerebrovasc Dis; 2016; 41(1-2):27-34. PubMed ID: 26579719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.
    Green AR
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S325-38. PubMed ID: 18059324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of drug repurposing combined with reperfusion therapy in cerebral ischemic stroke: A supplementary strategy to endovascular thrombectomy.
    Yang JL; Yang YR; Chen SD
    Life Sci; 2019 Nov; 236():116889. PubMed ID: 31610199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reperfusion Therapies in Acute Ischemic Stroke.
    Yeo LL; Tan BY; Yee W; Kulkarni A; Sharma VK
    Recent Pat CNS Drug Discov; 2015; 10(1):45-54. PubMed ID: 26129854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics.
    Liebeskind DS
    Curr Opin Neurol; 2010 Feb; 23(1):36-45. PubMed ID: 19926989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies.
    Rahme R; Yeatts SD; Abruzzo TA; Jimenez L; Fan L; Tomsick TA; Ringer AJ; Furlan AJ; Broderick JP; Khatri P
    J Neurosurg; 2014 Dec; 121(6):1354-8. PubMed ID: 25259569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective delivery platforms as an adjunct to mechanical thrombectomy.
    Babadjouni RM; Walcott BP; Liu Q; Tenser MS; Amar AP; Mack WJ
    Neurosurg Focus; 2017 Apr; 42(4):E4. PubMed ID: 28366053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models, neurovascular mechanisms and translational issues in stroke research.
    Lo EH
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S396-405. PubMed ID: 18157168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
    Gladstone DJ; Black SE; Hakim AM;
    Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Reperfusion Therapies in the Era of Mechanical Thrombectomy.
    Linfante I; Cipolla MJ
    Transl Stroke Res; 2016 Aug; 7(4):294-302. PubMed ID: 27221511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental neuroprotection in ischemic stroke: a concise review.
    Rajah GB; Ding Y
    Neurosurg Focus; 2017 Apr; 42(4):E2. PubMed ID: 28366067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.